DNA methyltransferases: a novel target for prevention and therapy.

Subramaniam D, Thombre R, Dhar A, Anant S. · 2014

Read DNA methyltransferases: a novel target for prevention and therapy. by Subramaniam D, Thombre R, Dhar A, Anant S. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4013461.txt.

Description

Dharmalingam Subramaniam, Ravi Thombre, Animesh Dhar, and Shrikant Anant review enzymes that mark DNA as drug targets in cancer, in Frontiers in Oncology in 2014. The enzymes, called DNA methyltransferases, place chemical tags on DNA that can switch genes off. Tag levels often run high in cancer tissue.

Extra tags can silence the guard genes that hold tumours back, helping cancers grow. One enzyme keeps tag patterns as cells divide, while others lay new tags down. Raised levels of the newer-tag enzymes show up in many cancer types and cell lines. Blocking these enzymes in tests cut tumour growth, in part by waking silenced guard genes. The enzymes also help sustain colon cancer stem cells, the seed cells that regrow tumours. Plant compounds in food can block them too. The review frames the family as a target for both prevention and treatment.

Catalog record

CREATORSubramaniam D, Thombre R, Dhar A, Anant S.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE76 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4013461

Browse the full library · About the Tower of Babel